Literature DB >> 15136495

Clinical recovery from end-stage heart failure using left-ventricular assist device and pharmacological therapy correlates with increased sarcoplasmic reticulum calcium content but not with regression of cellular hypertrophy.

C M N Terracciano1, J Hardy, E J Birks, A Khaghani, N R Banner, M H Yacoub.   

Abstract

BACKGROUND: Left ventricular assist device (LVAD) treatment is known to lead to structural and functional cellular modifications in the heart. The relevance of these changes for clinical recovery is unknown. METHODS AND
RESULTS: We compared properties of cardiomyocytes obtained from tissue taken at explantation of the LVAD in patients with clinical recovery with those obtained from hearts of patients who did not show clinical recovery, thus requiring transplantation. Compared with myocytes taken at implantation, both the recovery and nonrecovery groups showed approximately 50% reduction in cell capacitance, an index of cell size. However, action potential duration shortened, L-type Ca2+ current fast inactivation was more rapid, and sarcoplasmic reticulum Ca2+ content was increased in the recovery compared with the nonrecovery group.
CONCLUSIONS: These results show that specific changes in excitation-contraction coupling, and not regression of cellular hypertrophy, are specifically associated with clinical recovery after LVAD and further identify sarcoplasmic reticulum Ca2+ handling as a key functional determinant in patients with heart failure.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15136495     DOI: 10.1161/01.CIR.0000129233.51320.92

Source DB:  PubMed          Journal:  Circulation        ISSN: 0009-7322            Impact factor:   29.690


  37 in total

Review 1.  Reverse remodeling in heart failure--mechanisms and therapeutic opportunities.

Authors:  Norimichi Koitabashi; David A Kass
Journal:  Nat Rev Cardiol       Date:  2011-12-06       Impact factor: 32.419

2.  Bridge to recovery: understanding the disconnect between clinical and biological outcomes.

Authors:  Stavros G Drakos; Abdallah G Kfoury; Josef Stehlik; Craig H Selzman; Bruce B Reid; John V Terrovitis; John N Nanas; Dean Y Li
Journal:  Circulation       Date:  2012-07-10       Impact factor: 29.690

3.  Adult progenitor cell transplantation influences contractile performance and calcium handling of recipient cardiomyocytes.

Authors:  Joon Lee; Mark A Stagg; Satsuki Fukushima; Gopal K R Soppa; Urszula Siedlecka; Samuel J Youssef; Ken Suzuki; Magdi H Yacoub; Cesare M N Terracciano
Journal:  Am J Physiol Heart Circ Physiol       Date:  2009-01-30       Impact factor: 4.733

Review 4.  Cardiac contractility modulation therapy in advanced systolic heart failure.

Authors:  Alexander R Lyon; Michael A Samara; David S Feldman
Journal:  Nat Rev Cardiol       Date:  2013-08-13       Impact factor: 32.419

5.  Left ventricular remodeling and myocardial recovery on mechanical circulatory support.

Authors:  Marc A Simon; Brian A Primack; Jeffrey Teuteberg; Robert L Kormos; Christian Bermudez; Yoshiya Toyoda; Hemal Shah; John Gorcsan; Dennis M McNamara
Journal:  J Card Fail       Date:  2009-11-14       Impact factor: 5.712

6.  Regulation of connective tissue growth factor gene expression and fibrosis in human heart failure.

Authors:  Yevgeniya E Koshman; Nilamkumar Patel; Miensheng Chu; Rekha Iyengar; Taehoon Kim; Cagatay Ersahin; William Lewis; Alain Heroux; Allen M Samarel
Journal:  J Card Fail       Date:  2013-03-19       Impact factor: 5.712

7.  Morphological and molecular changes of the myocardium after left ventricular mechanical support.

Authors:  Hideo A Baba; Jeremias Wohlschlaeger
Journal:  Curr Cardiol Rev       Date:  2008-08

8.  Prolonged mechanical unloading affects cardiomyocyte excitation-contraction coupling, transverse-tubule structure, and the cell surface.

Authors:  Michael Ibrahim; Abeer Al Masri; Manoraj Navaratnarajah; Urszula Siedlecka; Gopal K Soppa; Alexey Moshkov; Sara Abou Al-Saud; Julia Gorelik; Magdi H Yacoub; Cesare M N Terracciano
Journal:  FASEB J       Date:  2010-04-29       Impact factor: 5.191

Review 9.  Sarcoplasmic reticulum Ca(2+) ATPase as a therapeutic target for heart failure.

Authors:  Larissa Lipskaia; Elie R Chemaly; Lahouaria Hadri; Anne-Marie Lompre; Roger J Hajjar
Journal:  Expert Opin Biol Ther       Date:  2010-01       Impact factor: 4.388

10.  Impaired calcium-calmodulin-dependent inactivation of Cav1.2 contributes to loss of sarcoplasmic reticulum calcium release refractoriness in mice lacking calsequestrin 2.

Authors:  Dmytro O Kryshtal; Oleksiy Gryshchenko; Nieves Gomez-Hurtado; Bjorn C Knollmann
Journal:  J Mol Cell Cardiol       Date:  2015-03-07       Impact factor: 5.000

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.